Beryl Drugs Ltd

Know More
NSEBSE
Stock not tradded

24.101.14 (4.97%)

04:01 PM,4th Dec 2023

BSE : 524606

NSE :

Sector : Health care

ISIN Code : INE415H01017

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Dec 04 2023 | 04:01 PM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Beryl Drugs Ltd

Beryl Drugs Ltd is engaged in the manufacture sale and export of branded generic pharmaceutical formulations in India and internationally. It offers I.V.fluids and a range of small and large volume injectables. The company also provides a range of eye/ear drops veterinary products and injections. It sells its products through its sales and distribution network. In addition the company offers research and development as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore India.Beryl Drugs Ltd was incorporated as a public limited company on August 24 1993. The company has taken over the running business of M/s Flora and Fauna Remedies on December 15 1993. The shares of Beryl Drugs were listed on M.P. Stock Exchange Bombay Stock Exchange and Ahmedabad Stock Exchange.Beryl has emerged into a global network of pharmaceutical manufacturing research and development contract manufacturing services and veterinary products. The manufacturing facilities of the company are in compliance with WHO GMP specifications.The company owns brands like BERI-CEF injection F-Neuron Amplicillin INJ P-Mol Biprox B-Flox and many more.The company has received ISO 9001:2000 certification for its quality management.

Beryl Drugs Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

12

EPS - TTM (₹) [S]

1.99

P/E Ratio (X) [S]

1.36

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]17.73
P/B Ratio (₹) [S]1.36
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

23.00

24.10

Week Low/High

20.19

24.10

Month Low/High

19.35

24.10

Year Low/High

11.05

25.00

All time Low/High

0.60

53.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week17.05%%4.394.51%
1 Month15.31%%6.997.57%
3 Month1.73%%4.935.93%
6 Month64.62%%10.1011.61%
1 Year101.00%%9.5410.65%
3 Year244.29%%52.7656.03%

Company Info

Company Information

ED / MD / Promoter : Sanjay Sethi

Chairman & Non Executive Dir. : Sudhir Sethi

Independent Non Exe. Director : Abhinav Naik

Independent Non Exe. Director : Shreya Saraf

Registered Office: 133 Kanchan Bag, ,Indore,Madhya Pradesh-452001 Ph: 91-731-25076375/3046366

Email:beryldrugs25@yahoo.com

URL:http://www.beryldurgs.com